The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Indian Medicinal Plants and Formulations and Their Potential Against COVID-19–Preclinical and Clinical Research
Open accessAbstract
The cases of COVID-19 are still increasing day-by-day worldwide, even after a year of its first occurrence in Wuhan city of China. The spreading of SARS-CoV-2 infection is very fast and different from other SARS-CoV infections possibly due to structural differences in S proteins. The patients with severe diseases may die due to acute respiratory distress syndrome (ARDS) caused by systemic inflammatory reactions due to the excessive release of pro-inflammatory cytokines and chemokines by the immune effector cells. In India too, it is spreading very rapidly, although the case fatality rate is below 1.50% (https://www.statista.com), which is markedly less than in other countries, despite the dense population and minimal health infrastructure in rural areas. This may be due to the routine use of many immunomodulator medicinal plants and traditional AYUSH formulations by the Indian people. This communication reviews the AYUSH recommended formulations and their ingredients, routinely used medicinal plants and formulations by Indian population as well as other promising Indian medicinal plants, which can be tested against COVID-19. Special emphasis is placed on Indian medicinal plants reported for antiviral, immunomodulatory and anti-allergic/anti-inflammatory activities and they are categorized for prioritization in research on the basis of earlier reports. The traditional AYUSH medicines currently under clinical trials against COVID-19 are also discussed as well as furtherance of pre-clinical and clinical testing of the potential traditional medicines against COVID-19 and SARS-CoV-2. The results of the clinical studies on AYUSH drugs will guide the policymakers from the AYUSH systems of medicines to maneuver their policies for public health, provide information to the global scientific community and could form a platform for collaborative studies at national and global levels. It is thereby suggested that promising AYUSH formulations and Indian medicinal plants must be investigated on a priority basis to solve the current crisis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
Rothan, H. A., & Byrareddy, S. N. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102433 · Cited by 5,840
Guo (2020) · doi:10.1186/s40779-020-00240-0 · Cited by 4,735
Jeong, Y., Ryu, J., Shin, J.-H., Kang, M., Kang, J., Han, J., & Kang, D. (2016) · Molecules · doi:10.3390/molecules21040430 · Cited by 148
Antibacterial activity of some Indian ayurvedic preparations against enteric bacterial pathogens
Tambekar, D., & Dahikar, S. (2011) · Journal of Advanced Pharmaceutical Technology & Research · doi:10.4103/2231-4040.79801 · Cited by 78
Rao, K., Ramesh, B., Girish, T., Raghavendra, R., Naidu, K., & Prasada Rao, U. J. S. (2014) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.129172 · Cited by 26
Cited by
IMPPAT 2.0: An Enhanced and Expanded Phytochemical Atlas of Indian Medicinal Plants
Vivek-Ananth, R. P., Mohanraj, K., Sahoo, A. K., & Samal, A. (2023) · ACS Omega · doi:10.1021/acsomega.3c00156 · Cited by 372
Phytobioactive compounds as therapeutic agents for human diseases: A review
Riaz, M., Khalid, R., Afzal, M., Anjum, F., Fatima, H., Zia, S., Rasool, G., Egbuna, C., Mtewa, A. G., Uche, C. Z., et al. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3308 · Cited by 355
Computational screening of umami tastants using deep learning
Dutta, P., Gajula, K., Verma, N., Jain, D., Gupta, R., & Rai, B. (2025) · Molecular Diversity · doi:10.1007/s11030-024-11006-4 · Cited by 6
Metadata
- Authors
- Ahmad, S., Zahiruddin, S., Parveen, B., Basist, P., Parveen, A., Gaurav, Parveen, R., & Ahmad, M.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2021-03-02
- Volume
- 11
- Pages
- 578970-578970
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W3134028605
- Cited by
- 213
- References
- 5
- FWCI
- 41.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Indian Medicinal Plants and Formulations and Their Potential Against COVID-19–Preclinical and Clinical Research. https://app.cochat.ai/papers/10.3389/fphar.2020.578970
- The paper
- Ahmad, S., Zahiruddin, S., Parveen, B., Basist, P., Parveen, A., Gaurav, Parveen, R., & Ahmad, M. (2021). Indian Medicinal Plants and Formulations and Their Potential Against COVID-19–Preclinical and Clinical Research. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2020.578970
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.